Viyash Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Viyash Scientific Limited (SEQUENT) share price today for real-time trading data and today's change.
Viyash Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Viyash Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Viyash Scientific Limited market cap and net worth for the company's overall valuation and market capitalisation.
Viyash Scientific Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viyash Scientific Limited ranked by their cash flow conversion efficiency. Also see SEQUENT current and non-current assets for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Start Group
SHG:600734
|
-0.075x |
|
Zhe Jiang Li Zi Yuan Food Co Ltd
SHG:605337
|
0.147x |
|
Shandong Shengli Co Ltd
SHE:000407
|
0.110x |
|
Allied Electronics Corporation Ltd
JSE:AEL
|
0.163x |
|
Empresa Distribuidora y Comercializadora Norte S.A.
BA:EDN
|
0.024x |
|
Pangaea Logistic
NASDAQ:PANL
|
0.061x |
|
Pagerduty Inc
NYSE:PD
|
0.094x |
|
ZJBC Information Technology Co Ltd
SHE:000889
|
0.058x |
Annual Cash Flow Conversion Efficiency for Viyash Scientific Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Viyash Scientific Limited from 2006 to 2025. Review financial flexibility index of Viyash Scientific Limited to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs7.70 Billion ≈ $83.31 Million |
Rs833.60 Million ≈ $9.02 Million |
0.108x | +152.16% |
| 2024-03-31 | Rs7.13 Billion ≈ $77.10 Million |
Rs305.95 Million ≈ $3.31 Million |
0.043x | +91.28% |
| 2023-03-31 | Rs7.49 Billion ≈ $81.02 Million |
Rs168.08 Million ≈ $1.82 Million |
0.022x | -45.73% |
| 2022-03-31 | Rs7.40 Billion ≈ $80.04 Million |
Rs305.95 Million ≈ $3.31 Million |
0.041x | -72.03% |
| 2021-03-31 | Rs7.76 Billion ≈ $83.96 Million |
Rs1.15 Billion ≈ $12.41 Million |
0.148x | -6.20% |
| 2020-03-31 | Rs7.32 Billion ≈ $79.15 Million |
Rs1.15 Billion ≈ $12.47 Million |
0.158x | +1.45% |
| 2019-03-31 | Rs7.47 Billion ≈ $80.78 Million |
Rs1.16 Billion ≈ $12.55 Million |
0.155x | +135.05% |
| 2018-03-31 | Rs6.85 Billion ≈ $74.03 Million |
Rs452.39 Million ≈ $4.89 Million |
0.066x | +1013.61% |
| 2017-03-31 | Rs9.94 Billion ≈ $107.50 Million |
Rs-71.90 Million ≈ $-777.57K |
-0.007x | -12597.48% |
| 2016-03-31 | Rs9.48 Billion ≈ $102.51 Million |
Rs-540.00K ≈ $-5.84K |
0.000x | +99.94% |
| 2015-03-31 | Rs2.38 Billion ≈ $25.76 Million |
Rs-235.49 Million ≈ $-2.55 Million |
-0.099x | +86.47% |
| 2014-03-31 | Rs613.06 Million ≈ $6.63 Million |
Rs-447.85 Million ≈ $-4.84 Million |
-0.731x | -1803.87% |
| 2013-03-31 | Rs995.83 Million ≈ $10.77 Million |
Rs-38.21 Million ≈ $-413.23K |
-0.038x | -116.25% |
| 2012-03-31 | Rs1.28 Billion ≈ $13.84 Million |
Rs302.36 Million ≈ $3.27 Million |
0.236x | -37.08% |
| 2011-03-31 | Rs1.35 Billion ≈ $14.60 Million |
Rs506.60 Million ≈ $5.48 Million |
0.375x | +148.36% |
| 2010-03-31 | Rs1.12 Billion ≈ $12.09 Million |
Rs168.95 Million ≈ $1.83 Million |
0.151x | +223.00% |
| 2009-03-31 | Rs405.20 Million ≈ $4.38 Million |
Rs-49.79 Million ≈ $-538.46K |
-0.123x | -14561.60% |
| 2008-03-31 | Rs573.71 Million ≈ $6.20 Million |
Rs487.47K ≈ $5.27K |
0.001x | -99.26% |
| 2007-03-31 | Rs349.24 Million ≈ $3.78 Million |
Rs40.21 Million ≈ $434.91K |
0.115x | -68.51% |
| 2006-03-31 | Rs198.08 Million ≈ $2.14 Million |
Rs72.43 Million ≈ $783.26K |
0.366x | -- |
About Viyash Scientific Limited
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more